Literature DB >> 19141502

NICE and the challenge of cancer drugs.

James Raftery1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19141502     DOI： 10.1136/bmj.b67

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Health care costs: how do we decide value? When do we decide? How do we particularize the decisions?

Authors:  Richard L Theriault
Journal:  Oncologist       Date:  2012-02-02

Review 2.  Analysis of economic evaluations of pharmacological cancer treatments in Spain between 1990 and 2010.

Authors:  Angel Sanz-Granda; Alvaro Hidalgo; Juan E del Llano; Joan Rovira
Journal:  Clin Transl Oncol       Date:  2012-11-21       Impact factor: 3.405

Review 3.  When is cancer care cost-effective? A systematic overview of cost-utility analyses in oncology.

Authors:  Dan Greenberg; Craig Earle; Chi-Hui Fang; Adi Eldar-Lissai; Peter J Neumann
Journal:  J Natl Cancer Inst       Date:  2010-01-07       Impact factor: 13.506

Review 4.  Predictive biomarkers: a paradigm shift towards personalized cancer medicine.

Authors:  Nicholas B La Thangue; David J Kerr
Journal:  Nat Rev Clin Oncol       Date:  2011-08-23       Impact factor: 66.675

5.  The economic pressures for biosimilar drug use in cancer medicine.

Authors:  Paul Cornes
Journal:  Target Oncol       Date:  2012-01-17       Impact factor: 4.493

6.  Rapid reviews may produce different results to systematic reviews: a meta-epidemiological study.

Authors:  Iain J Marshall; Rachel Marshall; Byron C Wallace; Jon Brassey; James Thomas
Journal:  J Clin Epidemiol       Date:  2018-12-25       Impact factor: 6.437

7.  The cost-effectiveness of transcatheter aortic valve implantation: exploring the Italian National Health System perspective and different patient risk groups.

Authors:  V Lorenzoni; G Barbieri; F Saia; F Meucci; G L Martinelli; A G Cerillo; S Berti; P Candolfi; G Turchetti
Journal:  Eur J Health Econ       Date:  2021-05-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.